Tus-Pharmaceutical Group Co., Ltd.

Shenzhen Stock Exchange 000590.SZ

Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure for the year ending December 31, 2023: USD -3.10 M

Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure is USD -3.10 M for the year ending December 31, 2023, a -14.67% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -2.71 M, a 33.51% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -4.07 M, a 21.60% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -5.19 M, a -0.92% change year over year.
Tus-Pharmaceutical Group Co., Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -5.15 M, a -56.73% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shenzhen Stock Exchange: 000590.SZ

Tus-Pharmaceutical Group Co., Ltd.

CEO	Ms. Ting Tang
IPO Date	Jan. 19, 1996
Location	China
Headquarters	No. 33, Yangliu Road
Employees	1,237
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Personal Care Tobacco

Description

Tus-Pharmaceutical Group Co., Ltd. manufactures and sells traditional Chinese medicine and western medicine products. The company was formerly known as Tus-Guhan Group Corp.,Ltd. Tus-Pharmaceutical Group Co., Ltd. was founded in 1956 and is based in Hengyang, China.

Key trends

Past 5 years